Bravecto ® Chewable Tablets for Dogs
Flavored chewable tablets for the treatment of tick and flea infestations on Dogs.
Description:
For the treatment of tick and flea infestations on dogs for 3 months. This veterinary medicinal product is a systemic insecticide and acaricide with a long duration of action that provides immediate and persistent tick and flea killing activity for 3 months.
Composition:
Each chewable tablet contains:
| Bravecto® chewable tablets | Fluralaner (mg) |
| For Very small dogs (2 – 4.5 kg) | 112.5 |
| For small dogs (> 4.5 – 10 kg) | 250 |
| For medium-sized dogs (>10 – 20 kg) | 500 |
| For large dogs (> 20 – 40 kg) | 1000 |
| For very large dogs (> 40 – 56 kg) | 1400 |
Indications for use:
For the treatment of tick and flea infestations on dogs for 3 months. This veterinary medicinal product is a systemic insecticide and acaricide with a long duration of action that provides immediate and persistent tick (adult and juvenile Ixodes ricinus, Ixodes hexagonus, Ixodes scapularis, Ixodes holocyclus, Dermacentor reticulatus, Dermacentor variabilis and Rhipicephalus sanguineus) and flea (Ctenocephalides felis and Ctenocephalides canis) killing activity for 3 months.
Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. The onset of effect is within 8 hours of attachment for fleas (C. felis) and 12 hours of attachment for ticks (I. ricinus). The product provides protection against transmission of Babesia canis by Dermacentor reticulatus ticks by killing the ticks before disease transmission occurs. This has been shown over a 3 months period after treatment.
The product effectively controls environmental flea populations in areas to which treated dogs have access. Can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD).
For the treatment of Demodicosis caused by Demodex spp. mites. In a controlled trial, treatment with fluralaner resulted in the complete removal of Demodex spp. mites from treated dogs.
For the treatment of Sarcoptic mange and Otodectes spp. mite infestations.
A single treatment prevents Dipylidium caninum (Dog Tapeworm) transmission from infected fleas to susceptible dogs for 3 months.
Precautions:
Bravecto® chewable tablets should not be used in puppies less than 8 weeks of age or weighing less than 2kg.
Contraindications:
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Storage:
Do not store above 30°C.
Presentation:
Fluralanar 112.5 mg/ 500 mg/ 1000 mg/ 1400 mg
Refer to Product Leaflet for more information.